Real-world use of nirmatrelvir-ritonavir: who benefits?

被引：1
|
作者：
Molina, Kyle C. [1 ,2 ]
Ginde, Adit A. [1 ]
机构：
[1] Colorado Univ, Dept Emergency Med, Sch Med, Aurora, CO 80045 USA
[2] Scripps Hlth, La Jolla, CA 92037 USA
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 07期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S1473-3099(23)00180-9
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：765 / 767
页数：3
相关论文
共 50 条
  • [21] Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study
    Qiu, Ye
    Wen, Hao
    Wang, Haoru
    Sun, Wenjun
    Li, Guangchao
    Li, Shaoqiang
    Wang, Yan
    Zhai, Jingnan
    Zhan, Yangqing
    Su, Yutian
    Long, Zhiwei
    Li, Zhengtu
    Ye, Feng
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study
    Han, Xiaobo
    Gao, Darui
    Li, Chenglong
    Yuan, Xin
    Cui, Junchang
    Zhao, Weiguo
    Xie, Fei
    Wang, Kaifei
    Liu, Yuhong
    Muo, Guoxin
    Xi, Na
    Zheng, Mengli
    Wang, Rentao
    Xiao, Kun
    Zhao, Dahui
    Zhang, Xinxin
    Han, Xinjie
    Wang, Bo
    Zhang, Tiantian
    Xie, Wuxiang
    Xie, Lixin
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [23] The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data
    Petrakis, Vasilios
    Rafailidis, Petros
    Trypsianis, Grigorios
    Papazoglou, Dimitrios
    Panagopoulos, Periklis
    [J]. VIRUSES-BASEL, 2023, 15 (04):
  • [24] Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19
    Anderson, Annaliesa S.
    Caubel, Patrick
    Rusnak, James M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1047 - 1049
  • [25] Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy
    Cohen, Myron S.
    Brown, Elizabeth R.
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1672 - 1673
  • [26] Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
    Hammond, Jennifer
    Yunis, Carla
    Fountaine, Robert J.
    Luscan, Gerald
    Burr, Aimee M.
    Zhang, Wuyan
    Wisemandle, Wayne
    Soares, Holly
    Baniecki, Mary Lynn
    Hendrick, Victoria M.
    Kalfov, Veselin
    Pypstra, Rienk
    Rusnak, James M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03): : 224 - 234
  • [27] Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
    Wong, Grace Lai-Hung
    Yip, Terry Cheuk-Fung
    Lai, Mandy Sze-Man
    Wong, Vincent Wai-Sun
    Hui, David Shu-Cheong
    Lui, Grace Chung-Yan
    [J]. JAMA NETWORK OPEN, 2022, 5 (12) : e2245086
  • [28] Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data
    Liu, Ting-Hui
    Huang, Po-Yu
    Wu, Jheng-Yan
    Chuang, Min-Hsiang
    Hsu, Wan-Hsuan
    Tsai, Ya-Wen
    Chang, Chih-Cheng
    Lai, Chih-Cheng
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (05)
  • [29] Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study
    Aggarwal, Neil R.
    Molina, Kyle C.
    Beaty, Laurel E.
    Bennett, Tellen D.
    Carlson, Nichole E.
    Mayer, David A.
    Peers, Jennifer L.
    Russell, Seth
    Wynia, Matthew K.
    Ginde, Adit A.
    [J]. LANCET INFECTIOUS DISEASES, 2023, 23 (06): : 696 - 705
  • [30] Real-World Evidence of the Top 100 Prescribed Drugs in the USA and Their Potential for Drug Interactions with Nirmatrelvir; Ritonavir
    Gerhart, Jacqueline
    Draica, Florin
    Benigno, Michael
    Atkinson, Jo
    Reimbaeva, Maya
    Francis, Domenick
    Baillon-Plot, Nathalie
    Sidhu, Gurinder Singh
    Damle, Bharat D.
    [J]. AAPS JOURNAL, 2023, 25 (05):
12345